Literature DB >> 8125713

Complement system and host defense against staphylococcal endophthalmitis.

M J Giese1, B J Mondino, B J Glasgow, H L Sumner, S A Adamu, H P Halabi, H J Chou.   

Abstract

PURPOSE: The authors studied the role of the complement system in host defense against Staphylococcus epidermidis and S. aureus endophthalmitis.
METHODS: Guinea pigs in the S. epidermidis model received an intravitreal injection of 7000 viable organisms, and guinea pigs in the S. aureus model received 50 viable organisms. The experimental animals in each model were decomplemented with intraperitoneal (IP) injections of cobra venom factor, whereas the control animals received IP injections of normal saline. Mean log bacterial counts in the vitreous and mean serum complement titers were compared in the experimental and control animals in each model on days 1, 2, 3, and 7.
RESULTS: In the S. epidermidis model, mean log bacterial counts in the vitreous were significantly higher in the experimental group than the control group on days 1 and 2 (P < 0.01) and on day 3 (P < 0.05). Mean serum complement titers were significantly lower in the experimental group at all days (P < 0.01). In the S. aureus model, mean log bacterial counts in the vitreous were significantly higher in the experimental group than the control group on day 2 (P < 0.05) and day 3 (P < 0.01). Mean serum complement titers were significantly lower in the experimental group on days 1, 2, and 3 (P < 0.01), but not on day 7.
CONCLUSION: These results suggest that decomplemented guinea pigs show impaired host defense to S. epidermidis and S. aureus endophthalmitis and that this defense is restored as complement levels approach normal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8125713

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Vitronectin-binding staphylococci enhance surface-associated complement activation.

Authors:  F Lundberg; T Lea; A Ljungh
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

Review 2.  Modeling intraocular bacterial infections.

Authors:  Roger A Astley; Phillip S Coburn; Salai Madhumathi Parkunan; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2016-05-03       Impact factor: 21.198

Review 3.  Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.

Authors:  Michelle C Callegan; Michael Engelbert; David W Parke; Bradley D Jett; Michael S Gilmore
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 4.  Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions.

Authors:  Michelle C Callegan; Michael S Gilmore; Meredith Gregory; Raniyah T Ramadan; Brandt J Wiskur; Andrea L Moyer; Jonathan J Hunt; Billy D Novosad
Journal:  Prog Retin Eye Res       Date:  2007-01-22       Impact factor: 21.198

Review 5.  The Pathogenesis of Staphylococcus aureus Eye Infections.

Authors:  Richard J O'Callaghan
Journal:  Pathogens       Date:  2018-01-10

6.  Innate Immune Interference Attenuates Inflammation In Bacillus Endophthalmitis.

Authors:  Md Huzzatul Mursalin; Phillip S Coburn; Frederick C Miller; Erin T Livingston; Roger Astley; Michelle C Callegan
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.